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Abstract Human lymphoblastoid cells of normal origin and
from genetic instability syndromes, i.e. Fanconi anemia (FA)
group C and ataxia telangectasia, were continuously exposed to
extremely low frequency magnetic field (ELF-MF). We report
that ELF-MF, though not perturbing cell cycle progression,
increases the rate of cell death in normal cell lines. In contrast,
cell death is not affected in cells from genetic instability
syndromes; this reflects a specific failure of the apoptotic
response. Reintroduction of complementation group C in FA cells
re-established the apoptotic response to ELF-MF. Thus, genes
implicated in genetic instability syndromes are relevant in
modulating the response of cells to ELF-MF. ß 2001 Federa-
tion of European Biochemical Societies. Published by Elsevier
Science B.V. All rights reserved.
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1. Introduction
Human exposure to extremely low frequency electromag-
netic ¢eld (ELF-EMF) has dramatically increased in the last
decades in developed countries (reviewed in [1,2]). This has
raised considerable interest in the biological activity of EMFs.
A large number of epidemiological and biological studies,
largely reviewed in [2^5], have been carried out with the
dual aim of (i) establishing whether any correlation exists
between EMFs and tumors and (ii) elucidating possible modes
of action [2,6,7]. While there is a consensus that EMFs in£u-
ence certain cellular processes, no de¢nite conclusion has been
drawn as yet on the potential health hazard associated with
EMF, due to both the di⁄culty of de¢ning exposure condi-
tions and to the multiplicity of sources and adopted protocols
(reviewed in [4,5]). Actually, the broad variations in exposure
protocols in di¡erent laboratories make any direct compari-
son from independent studies extremely di⁄cult to draw. Sev-
eral studies have reported a co-stimulatory e¡ect of ELF-
EMF on lymphocyte proliferation, while inhibitory e¡ects
were recorded by other laboratories ([2,6] and references
therein). Besides methodological di¡erences among published
studies, another possible explanation of the discrepancies may
come from the observation that the response to EMF is highly
dependent on the samples under study, and can vary with the
age and/or state of health of donors, as well as the stimulation
conditions in work with cultured cell lines. It is generally
established that cells from old and diseased donors, as well
as sub-optimally stimulated cells, are more sensitive to ELF-
EMF than their ‘healthy’ counterparts ([8^10] ; see also [11]
for review).
Cells from human genetic instability syndromes are charac-
terized by hypersensitivity to various genotoxic agents, defec-
tive repair and checkpoint controls and an increased incidence
of cancers [12]. Examining the biological response of cells
from such syndromes may help to pinpoint the pathways of
genomic instability associated with the onset of neoplastic
growth in the general population, and to identify environmen-
tal risks that may be particularly damaging to an individual
carrying these disorders. Here we have studied the e¡ects of
ELF-EMF on human cells with di¡erent genetic background,
i.e. lymphocytes from healthy donors and human lymphoblas-
toid cell lines of either normal origin or derived from two
genetic instability syndromes, i.e. ataxia telangectasia (AT)
and Fanconi anemia (FA). AT is a genetic disorder charac-
terized by the recessive ATM mutation. The wild-type ATM
gene encodes a protein kinase of the phosphatidylinositol 3-
kinase superfamily, which is emerging as a versatile protein
implicated in signalling pathways regulating cell cycle check-
points, induction of DNA repair in response to ionizing radi-
ations and apoptosis (reviewed in [13^15]). FA is also a re-
cessive disorder, and is regarded as a DNA repair-defective
syndrome associated with chromosomal instability, hypersen-
sitivity to DNA damaging agents, and high predisposition to
cancer particularly of myeloid origin (reviewed in [12,16,17]).
A complex genetic determination underlies the syndrome:
eight complementation groups are identi¢ed [18], four of
which, termed A, C, F and G, have been cloned (reviewed
in [17]; also see [19]).
Here we have examined a normal lymphoblastoid cell line
(AHH1); two cell lines independently derived from homozy-
gous patients for the ATM mutation; a FA cell line carrying a
homozygous mutation in complementation group C
(FANCC) [20]; and its corrected counterpart derived by sta-
ble transfection of the wild-type gene [21]. Experiments have
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been carried out in two laboratories in Rome and Milan
under identical extremely low frequency magnetic ¢eld
(ELF-MF) exposure conditions. We report that (i) ELF-
MFs do not a¡ect the cell cycle in normal or genetic insta-
bility syndrome-derived cells ; (ii) however, the spontaneous
rate of cell death, revealed by both ultrastructural modi¢ca-
tions and by the appearance of hypodiploid apoptotic cells in
the cell population, signi¢cantly increases in healthy lympho-
cytes and in normal lymphoblastoid cells exposed to MF for
over 72 h; (iii) in contrast, cells from the AT and FA syn-
dromes fail to allow a signi¢cant apoptotic response to MF
exposure; (iv) correction of the FA defect by transfection of
the wild-type gene restores MF sensitivity.
2. Materials and methods
2.1. ELF-MF exposure apparatus
Experiments were carried out in laboratories in Rome and Milan
using identical Helmholtz coils that generated a linearly polarized
magnetic ¢eld. The magnetic ¢eld strength (H) was axial and was
parallel to the coil axis. The magnetic ¢eld (50 Hz) was measured
using a calibrated ELF-MF detector for frequencies below 100 Hz
to ensure that the Helmholtz coil generated a uniform distribution
accross the exposed surface. The apparatus frame was built in te£on
with no glue, adhesive or degassing material and hence was totally
chemically inert. The Helmholtz coil unit consists of two coils (35
turns each) made of 1 mm diameter enameled wire. The distance
between the coils was set to obtain a peak magnetic induction of 60
WT at the center of the unit (e.g. where samples are placed during the
experiment) and 58 WT at the radial position, corresponding to the
outer edge of the dish. The 50 Hz signal was derived by a small
transformer separated from the power supply circuitry. The signal
obtained at the secondary winding was mostly free of higher harmonic
distortion; furthermore, to ensure the highest spectral purity of the
sinusoidal drive, the transformer output was passed through a two-
section passive low-pass ¢lter, which strongly attenuated all higher
harmonics (mainly 100 and 150 Hz). FFT analysis of the signal in-
dicated that less than 1% of the total spectral power was associated
with higher harmonics. Line transients were eliminated by a two-sec-
tion cascaded LC ¢lter on the 220 V main. Spikes due to switching of
neighboring equipment never appeared as noise in the coil current
trace. The current-monitoring resistor included in the voltage-to-cur-
rent converter is strictly non-inductive and does not act as a pickup
even when the Helmholtz coils are placed in the vicinity of the power
supply (a condition that was avoided in the present experiments). The
wires do not warm up under standard conditions. The total wire re-
sistance for a single coil is in the range of 0.3 6 and the peak current
is 0.25 A: thus, the Joule dissipation is negligible. Local heating-up of
the wire can be ruled out as the skin e¡ect at 50 Hz is also negligible.
The magnetic ¢eld intensity in Rome is about 46 WT, the angle of
declination 0.16‡ eastward and the inclination 360‡ downward with
respect to the horizontal plan. The 50 Hz magnetic ¢eld was normal
to the horizontal plan. It is assumed that the dc bias due to the
terrestrial ¢eld does not signi¢cantly a¡ect the experiments, as similar
tests performed at di¡erent latitudes show similar results.
2.2. MF exposure
Cell cultures were split immediately before starting the experiment
into two culture dishes (60U15 mm, Falcon) placed in the same hu-
midi¢ed (84% H2O) 5% CO2 incubator at 37‡C. The Helmholtz coil
was placed in the upper left tray of the incubator with the culture dish
to be MF-exposed, whereas the control culture dish was placed in the
lower right tray where the background MF was lower than 0.01 WT.
The temperature in the incubator was regularly monitored and was
found to remain constant throughout the duration of the experiments.
2.3. Cell lines
Human immortalized lymphoblastoid cell lines include: AHH1,
from a healthy donor; AT3189 and AT2782B, from two patients
carrying homozygous mutations at the ATM locus; HSC536, from
a patient carrying a homozygous mutation in the FANCC gene; and
FACC11, resulting from the stable transfection of HSC536 cells with
FANCC gene. Correction of the FA phenotype was previously dem-
onstrated by assessing the acquired resistance to mitomycin C in the
complemented but not in the parental HSC536 cell line [21]. Genet-
ically characterized cell lines from genetic instability syndromes were a
kind gift from F. Rosselli (CNRS Institut pour la Recherche sur le
Cancer, Villejuif, France). Phytohaemagglutinin-stimulated lympho-
cyte cultures were set up from the peripheral blood of 10 healthy
volunteers (seven females and three males, 32^49 years of age). 6 ml
of blood were collected in heparinized tubes. A smear of each sample
was stained with May Grunwald Giemsa: lymphocytes represented
20^38%, while monocytes ranged from 2 to 5%. Mononuclear cells
were isolated using Histopaque-1077 (Sigma Diagnostics, Milan,
Italy) according to the manufacturer’s instructions. Peripheral lym-
phocyte cultures and lymphoblastoid AHH1 cells were routinely
grown in RPMI 1640 medium supplemented with 10% fetal bovine
serum (HyClone, Logan, UT, USA); syndrome-derived cell lines were
cultured in the presence of 15% fetal bovine serum.
2.4. Electron microscopy
Control and exposed cells were resuspended in 2.5% glutaraldehyde
in cacodylate bu¡er for 1 h at 4‡C, washed in 0.1 M cacodylate bu¡er
(pH 7.4), dehydrated end embedded in Epon-Araldite mixture (Fluka,
Buchs, Switzerland). Thin sections were stained with toluidine blue,
whereas ultra-thin sections were stained with uranyl acetate and lead
citrate and examined under a Zeiss EM 109 electron-microscope (Carl
Zeiss, Oberkochen, Germany) at 80 kW. Cell preparations were coded
and independently analyzed by two ‘blind’ operators.
2.5. Fluorescence-activated cell sorter (FACS) analysis
To monitor cell cycle progression, cell cultures were exposed to 45
WM bromodeoxyuridine (BrdUrd) for the last 30 min before harvest-
ing. Cells were ¢xed in 70% ethanol, washed in phosphate-bu¡ered
saline (PBS)/Tween 20 (0.5%) and incubated in 3 N HCl for 45 min;
after partial DNA denaturation, cells were exposed to anti-BrdUrd
antibody (IgG clone BU 20a, Dako, Glostrup, Denmark), to second-
ary £uorescein-conjugated anti-mouse IgG antibody (Vector Labora-
tories, Burlingame, CA, USA) and subjected to biparametric analysis
(WinMDI software) for simultaneous determination of BrdUrd incor-
poration and of the DNA content [22].
To detect apoptosis, two di¡erent £ow-cytometry methods were
employed: (1) determination of hypodiploid cells [23]: brie£y, 106
cells were resuspended in PBS containing 0.1% Triton-X 100 and
100 U/ml RNase A (Sigma, St. Louis, MO, USA), stained with 20
Wg/ml propidium iodide (Sigma, St. Louis, MO, USA) and analyzed
using a FACStar plus (Becton-Dickinson) £ow-cytometer (10 000
events per sample). The ampli¢cation scale was logarithmic for
FSC-H and FL2-H parameters, and linear for SSC-H, FL2-A and
FL2-W. The photomultiplier voltage was set so as to place the peak
corresponding to 2C DNA content (G0/G1) at channel 200 in the
FL2-A histogram. (2) Detection of dislocated phosphatidylserine res-
idues on the outer cell membrane by annexin V^£uorescein isothio-
cyanate binding [24]. 106 cells were washed in PBS, resuspended in
0.1 ml binding bu¡er (10 mM HEPES, 140 mM NaCl, 2 mM CaCl,
5 mM KCl, 1 mM MgCl2) containing 20 Wl/ml annexin V^Fluos
(Boehringer Mannheim) and incubated for 15 min at room temper-
ature in the dark. Samples were then diluted by adding 0.4 ml binding
bu¡er and analyzed by FACS using a linear ampli¢cation scale for
FSC-H and a log scale for FL1-H.
3. Results and discussion
3.1. ELF-MFs do not a¡ect cell cycle progression in
lymphoblastoid cell lines
Human hematopoietic cells with di¡erent genetic back-
grounds were exposed to continuous ELF-MF (50 Hz, 60
WT) and aliquots containing approximately 106 cells were har-
vested 0, 24, 48 and 72 h after exposure to be analyzed. Pre-
liminary experiments using the trypan blue exclusion assay
indicated that the basal viability of non-exposed cultures
was comparable in all cell lines, ranging from 80% in
AHH1 to 89% in HSC536 (mutant cell line in the FANCC
complementation group) cultures. Lymphocyte cultures from
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all donors were also comparable, with a mean viability of
96 þ 4%. A ¢rst set of experiments was designed to assess
cell cycle progression in the presence or absence of MF. If
MF exposure evoked a damage checkpoint, then the cell cycle
phase distribution may have been a¡ected in exposed com-
pared to control samples. Flow cytometric analysis of the
genome size and of BrdUrd incorporation in replicating
DNA enabled us to accurately determine the cell cycle phase
distribution in each sample [22]. In Fig. 1, cell cycle progres-
sion is indicated by the percentage of G1 cells recorded at
di¡erent times in the presence or absence of MF. Similar
cell cycle pro¢les were recorded in MF-exposed and control
cultures, regardless of normal, AT or FA background. All
samples showed typical pro¢les of actively proliferating, asyn-
chronous cultures during 72 h of exposure, roughly account-
ing for three cell division cycles.
3.2. Continuous exposure to ELF-MF increases the
spontaneous rate of cell death in normal lymphocytes and
lymphoblastoid cells, but not in FA or AT cell lines
After 72 h of exposure to ELF-MF, we noticed the fraction
of G1 phase cells increased in all cell lines (Fig. 1); this was
paralleled by a corresponding decrease in the number of
S phase cells (data not shown). The G1 enrichment re£ects
a decline in the proliferating ability of the cultures, probably
due to accumulation of cell metabolites and medium spoilage,
which is typically accompanied by cell death in lines of hem-
atopoietic origin. To further investigate this, cell death was
directly examined by electron microscopy in all cell lines.
Normal cells were ¢rst characterized in primary lymphocyte
cultures from healthy individuals and in AHH1 cultures (Figs.
2A and 3A, respectively) : prominent nucleoli and distinct cy-
toplasmic borders can be seen in a clear background without
cell debris. MF-exposed samples showed submicroscopical
changes ranging from reversible injuries (including minor
plasma membrane alterations, mitochondrial changes, dilata-
tion of the endoplasmic reticulum and nuclear alterations with
disruption of granular and ¢brillar elements), to truly necrotic
and apoptotic morphologies. Apoptosis was characterized by
the presence of highly condensed chromatin generally at the
nuclear periphery, nuclear fragmentation and cell shrinkage
(Figs. 2B,C and 3B^D). In Fig. 3B for example a late apo-
ptotic cell can be seen, with interrupted plasma membrane,
intracellular vacuoli and apoptotic nuclear fragments. Ne-
crosis was characterized by overt discontinuities in plasma
membranes, marked dilatation of mitochondria, intracyto-
plasmic myelin ¢gures and osmophilic debris (Figs. 2D,E
and 3E).
Since a controversial aspect in studies of MF e¡ects on
cellular systems is the reproducibility of MF-induced patterns,
seven independent experiments were carried out with each cell
line and coded. Two operators, both blinded to the code cor-
responding to each cell line and treatment, determined the
number of aberrant ¢gures in samples of 100 cells in each
experiment. Table 1 summarizes the statistical analysis of
these experiments. Morphologically aberrant cells and sponta-
neous cell death were recorded among both MF-exposed and
control cultures after 72 h of incubation. However, a highly
signi¢cant increase in the rate of cell death was measured in
MF-exposed compared to control samples from normal lym-
phocytes and AHH1 cultures. No signi¢cant di¡erences were
Fig. 1. Cell cycle progression in the presence or absence of MF.
The graphs show the % of G1 phase cells in AHH1, AT (AT 3189
and AT 2782B), FA (HSC536) and FA cells transfected with com-
plementation group C (FACC11) after the indicated times of incu-
bation in the presence (MF) or absence (ctr) of MF. Three experi-
ments were carried out with each cell line; representative panels are
shown.
Table 1
Cell death (%) in cell lines exposed to LF-MF for 72 h as assessed by electron microscopy
Lymphocytes AHH1 cells AT 3189 cells HSC536 cells FACC11 cells
control MF control MF control MF control MF control MF
Mean 8.29 19.43 17.01 26.43 10.57 10.43 9.14 8.71 8.33 13.33
S.E.M. 1.83 4.68 2.88 3.46 6.27 4.49 1.81 2.49 2.56 1.49
P 0.0005*** 0.0005*** 0.0001*** 0.0001*** 0.9108 0.9108 0.7178 0.7178 0.0037** 0.0037**
Seven experiments were carried out; 100 cells from control and MF-exposed cultures were analyzed in each experiment. S.E.M.: standard error.
P-values were calculated using the Student two-tailed t-test: **highly signi¢cant; ***extremely highly signi¢cant.
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recorded between MF-exposed and control cells from FA and
AT syndromes. Correction of FA cells by transfection of the
FANCC gene (FACC11 cell line) restored the MF-induced
increase of cell death after 72 h.
3.3. The rate of apoptosis increases in normal lymphocytes and
lymphoblastoid cells exposed to ELF-MF, but not in FA or
AT cells
Both the AT [25,26] and FA [27,28] syndromes are gener-
ally defective in apoptosis in response to several stimuli, and
this feature is regarded as a determinant of their cancer-prone-
ness. Results in Table 1 suggest that the lack of MF-induced
cell death may re£ect a speci¢c failure of the apoptotic re-
sponse in AT and FA-derived cells. To investigate this ques-
tion, apoptosis induction was determined in MF-exposed and
control samples from all cell lines by biparametric FACS
analysis : cellular granularity and DNA content were eval-
uated by measuring the 90‡ light scatter (SSC) parameter
and the stoichiometric PI intercalation into DNA, respectively
[23]. Apoptosis is revealed by the appearance of a population
of highly condensed, granular cells [high SSC], whose DNA
content is below 2C (see panels in Fig. 4A). AHH1 cultures
underwent a low level of spontaneous apoptosis during the
¢rst 72 h of the experiment; after that time, the rate of spon-
taneous apoptosis began to increase. The increase was signi¢-
cantly greater in the presence of MF (Fig. 4B, left panel). In
contrast, cells from genetic instability syndromes failed to
undergo spontaneous apoptosis with time, and, furthermore,
failed to express an increased apoptotic response to MF ex-
posure: apoptotic rates remained very similar in MF-exposed
and non-exposed samples from syndrome-derived cells after
72 (Fig. 5B) and 120 h (data not shown) of incubation. The
di¡erent response between normal and cancer-prone cells did
not re£ect a di¡erence in proliferation rates, since the average
cell division time remained similar (24 h) in all lines as indi-
cated by the data in Fig. 1. FACS analysis con¢rmed that
corrected FA cells by the wild-type FANCC gene had a re-
stored ability to induce increased levels of apoptosis in re-
sponse to MF (Fig. 4B, right panel).
To further con¢rm these results, the annexin V binding
Fig. 2. Ultrastructural analysis of primary lymphocytes after 72 h of incubation in the absence (A, B) or presence (C^E) of MF. A: Well pre-
served morphology, with normal plasma membranes and mitochondria (original magni¢cation 3200U). B: Apoptotic cell with a peripheral cres-
cent-shaped mass of compact chromatin (original magni¢cation 7000U). C: Lymphocytes with intracytoplasmic vacuoli (arrows) and dilatation
of the perinuclear cisternae (original magni¢cation 4500U). D: Lymphocytes with dilated perinuclear cisternae (arrows), interrupted cell mem-
branes (arrowheads) and necrotic debris in the background (original magni¢cation 7000U). E: Irreversible injury: necrosis and cell debris (orig-
inal magni¢cation 3200U).
Fig. 3. Ultrastructural analysis of lymphoblastoid cells after incubation in the absence (A) or presence (B^E) of MF. A: AHH1 cells with well
preserved morphology, normal membranes and mitochondria. Several pseudopods and nucleoli are visible (original magni¢cation 3200U).
B: AHH1 late apoptotic cell with interrupted plasma membrane (open arrowhead), intracellular vacuoli (plain arrowhead) and nuclear frag-
ments with uniformly dense chromatin (arrows); no recognizable mitochondria (original magni¢cation 3200U). C: FACC11 apoptotic cell with
nuclear fragments with uniformly dense chromatin (arrows), interrupted cell membranes and intracellular vacuoli (original magni¢cation
3200U). D: AHH1 apoptotic cell with condensed, fragmented chromatin (arrows) (original magni¢cation 4500U). E: ACC11 necrotic cell (top),
neighbored by a cell (below) with evident cytoplasmic vacuoli (arrowhead) and dilated endoplasmic reticulum (original magni¢cation 3200U).
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assay was employed to independently assess the apoptotic
response in normal AHH1, AT 3189, FA HSC536 and FA-
corrected FACC11 cell lines. Annexin V speci¢cally binds to
phosphatidyl-serine residues which become externalized on
the outer cell membrane during the early phases of apoptosis
[24]. Fig. 5 shows the £ow-cytometry detection of apoptotic
cells by £uorescein-labeled annexin V after 72 h of exposure to
ELF-MF. ELF-MF exposure signi¢cantly increased the pro-
portion of annexin V-positive cells in the normal AHH1 cell
line but did not a¡ect the rate of apoptosis of either the AT
3189 or the FA HSC536 cell lines. Correction of the FA
defect in the FACC11 cell line fully restored the apoptotic
response to ELF-MF. Thus, measuring early apoptotic events
by annexin V gave fully consistent results with those obtained
by assessing the distribution of hypodiploid cells typical of
advanced apoptosis.
In summary, the present results show that a 50 Hz, 60 WT
MF, though not a¡ecting progression through the cell division
cycle, stimulates the spontaneous rate of cell death in human
healthy lymphocytes and normal lymphoblastoid cells. Pre-
vious studies suggested that MF exposure increases apoptosis
in rodent cells [29,30]. A novel aspect emerging from our
study is the defective apoptotic response to MF exposure of
cell lines derived from FA and AT syndromes, both of which
are characterized as repair-defective and cancer-prone. Cells
from human genetic instability syndromes have not been ex-
amined before in response to MF. Our results are generally
consistent with the notion that the origin and state of health
of cells are highly in£uential in the response to MF [11]. In
addition, our experiments suggest that both the ATM kinase
and the FA C gene product can in£uence the response to MF
exposure: two independent cell lines lacking ATM, and a cell
line carrying a homozygous mutation in the FANCC gene,
proved de¢cient in MF-induced apoptosis. Reintroduction
of the FANCC gene in defective cells restored the response
to MF exposure. A large body of work has recently focussed
on the role of ATM in checkpoint controls (reviewed in [13^
15]) : ATM is implicated in both p53-dependent and p53-in-
dependent apoptotic pathways [25,26] and a cytoplasmic frac-
tion of the ATM protein kinase pool is thought to play spe-
ci¢c roles in signal transduction [13^15]. The molecular role of
FANCC gene product is less clear, yet a general role in pre-
venting apoptosis is accepted [28,31], which can also be ex-
erted in a p53-independent manner [32,33]. The possibility
that ELF-MFs act on DNA is controversial [6,7,34,35]; there-
fore, the failure of AT and FA cells to undergo apoptosis in
response to MF exposure is not necessarily related to the
deregulated apoptotic response to genotoxic agents in these
syndromes, but may re£ect a more general impairment in
cellular signalling. MFs are thought to in£uence the intracel-
lular calcium £ux in cells of the immune system [30,36^38],
which is in turn a key factor in modulation of apoptosis.
Further work will be required to elucidate the molecular steps
implicated in the signalling pathways underlying the apoptotic
response to MF. From the data reported here, we believe that
an indication is beginning to emerge concerning the genetic
Fig. 4. Apoptotic response of lymphoblastoid cells in the presence or absence of MF. A: Examplifying FACS pro¢les of the apoptotic cell pop-
ulation in AHH1 cultures. B: Apoptosis frequency in AHH1 and syndrome-derived cell lines (AT 2782B, AT 3189, FA HSC536 and FACC11
transfected with complementation group C). Three experiments were carried out; histograms represent mean values (empty histograms, con-
trol; : black histograms, MF-exposed samples); bars represent standard errors. P-values between exposed and non-exposed samples after 72 h
of incubation were calculated using the Student two-tailed t-test; *Ps 0.1, **P6 0.05.
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background required for expression of the MF-sensitive phe-
notype.
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